Renaissance Technologies - TELA BIO INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TELA BIO INC
ValueSharesWeighting
Q3 2023$273
-42.6%
34,100
-27.4%
0.00%
-100.0%
Q2 2023$476
-35.8%
47,000
-32.6%
0.00%0.0%
Q1 2023$742
-6.1%
69,700
+1.4%
0.00%0.0%
Q4 2022$790
-99.9%
68,732
-1.8%
0.00%0.0%
Q3 2022$596,000
+618.1%
70,000
+488.2%
0.00%
Q2 2022$83,000
-38.5%
11,900
+13.1%
0.00%
Q4 2021$135,000
-64.9%
10,521
-62.7%
0.00%
Q3 2021$385,000
-47.6%
28,200
-38.2%
0.00%
-100.0%
Q2 2021$735,000
+70.1%
45,600
+57.2%
0.00%0.0%
Q1 2021$432,00029,0000.00%
Other shareholders
TELA BIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 1,833,989$25,052,0005.56%
Opaleye Management Inc. 443,199$6,054,0001.13%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 113,000$1,544,0000.56%
Orbimed Advisors 3,027,542$41,356,0000.45%
Parkman Healthcare Partners LLC 100,000$1,366,0000.35%
RTW INVESTMENTS, LP 1,391,619$19,010,0000.29%
SANDERS MORRIS HARRIS LLC 107,168$1,464,0000.27%
COWEN AND COMPANY, LLC 392,100$5,356,0000.25%
PURA VIDA INVESTMENTS, LLC 580,515$7,930,0000.24%
Granite Point Capital Management, L.P. 227,644$3,110,0000.24%
View complete list of TELA BIO INC shareholders